Tag
British startup Mass Balance launched a self-contained autonomous laboratory into orbit to study disease-causing disordered proteins under microgravity, aiming to generate data to train AI models for drug discovery. The test mission will validate the system's ability to run chemical experiments in space.
Professor Clare Bryant at the University of Cambridge is using DeepMind's Co-Scientist to rapidly identify molecular switches that cause severe diseases like sepsis when pathogens jump between species, cutting research time from years to months.
An Isomorphic Labs researcher shared their experience using Gemini 4 to summarize papers on protein targets and break down 500-page chemistry patents, reducing tasks that originally took one to two days or even a month to just over ten minutes and a single afternoon, with extremely high accuracy.